home FAQ email sign-up search contact us
Headlines Email Alert Sign-up
HealthCast Calendar
Daily Reports Health Poll Search
Issue Spotlight
<a href="http://www.kaisernetwork.org/daily_reports/rep_index.cfm"><img src="http://www.kaisernetwork.org/images/index_flash_headlines.gif" width="437" height="42" border=0></a>

AIDS 2008: Time to Deliver
Home

Guide to Webcast Coverage

Daily Roundup

Newsmaker Interviews

Mexico City Notebook

Conference Materials

 

This conference only
Related Resources
  > AIDS2008.org

  > Kaiser Family Foundation - KFF.org
  > kaisernetwork.org
  > kaiserEDU.org
  > GlobalHealthFacts.org
  > GlobalHealthReporting.org
  > Previous kaisernetwork.org AIDS Conference Coverage
  > Clinical Care Options

XVII International AIDS Conference: August 3-8, 2008

Late Breaker Track B Session 2
8/7/2008
Mexico City

  Email this webcast

For more information on this session, please see the conference Programme-at-a-Glance page.

 

Full version:

Video
Transcript
Podcast


Speakers for this session:

  Co-Chairs
 
  High Prevalence of Acute HIV Infection in Sub-Saharan Africa: A Cross Sectional, Multi-Centre Screening Study

Gift Kamanga (TBC)
Clinical Officer, UNC Project
Kamuzu Central Hospital



Abstract
 
  IDX899, A Novel HIV-1 NNRTI with High Barrier to Resistance, Provides Suppression of HIV Viral Load in Treatment-Naïve HIV-1-Infected Subjects

Carlos Zala, M.D.
Medical Director
Dra. Cecilia Grierson Fundacion



Abstract
 
  Antiviral Activity of RDEA806, A Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment of Näive HIV Patients

Graeme Moyle, M.D., M.B.B.S.
Director of HIV Research Strategy and Associate Specialist in HIV/GU Medicine
Chelsea and Westminster Hospital



Abstract
 
  PEARLS (ACTG A5175): A Multinational Study of Didanosine-EC, Emtricitabine and Atazanavir vs. Co-Formulated Zidovudine/lamivudine and Efavirenz for Initial Treatment of HIV-1 Infection

Thomas Campbell, M.D.
Associate Professor, Division of Infectious Diseases
University of Colorado at Denver Health Sciences Center



Abstract
 
  A Pivotal Biostudy Comparing Ritonavir 100 mg Film-Coated Tablet to a Ritonavir 100 mg Soft Gelatin Capsule in Healthy Adult Subjects

Barry Bernstein, M.D.
Global Project Head
Abbott Laboratories



Abstract
 
  High Rate of Virologic Success with Raltegravir Plus Etravirine and Darunavir/Ritonavir in Treatment-Experienced Patients with Multidrug-Resistant Virus: Results of the ANRS 139 TRIO Trial

Yazdan Yazdanpanah, M.D., Ph.D.
Service Universitaire des Maladies Infectieuses
Centre Hospitalier de Tourcoing



Abstract


 

EMAIL ALERTS
Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.
 
FAQS
More...
 
CONTACT US
Contact us by email with any comments, problems, suggestions.
Call the kaisernetwork.org Help Desk at 202-347-5270.
...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ......


About Us     Privacy Policy      Help      Site Map